Clinical Resources

Innovative and expert clinical education

Vascular Access Forum: Technological Innovations in Vascular Access, Perth 18th October 2016

Vascular Access Forum: Technologies Impacting Vascular Access, Sydney 10th May 2016

Video - ARROW VA AGB Science

VA Forum: Vascular Access: It's a Risky Business, Brisbane 24th November 2015

Arrow Bedside Ultrasound for Pneumothorax

IV Forum: Optimising Outcomes with PICCs - Mildura 1st April 2015

Philips Respironics V60 - Taking NIV Further

Respironics BiPAP Vision Noninvasive Ventilator

Respironics BiPAP Focus Noninvasive Ventilator

Teleflex Central Line Care & Maintenance Program

Brisbane IV Forum - Advancing Your Vascular Access Team - 9 April 2014

Tracey Patrick - Gold Coast Hospital “Advancing Your Vascular Access Team” Infusion Therapy PICC Services Gold Coast Hospital

Helen Hayes - Townsville Hospital “The Townsville Hospital Nurse Led PICC Journey

Perth IV Forum - Reducing Risk in Vascular Access - 25 March 2014

Crit-IQ AGB Advertisement with References October 2013

The ARROW® AGB+ Central Venous Catheter is treated with chlorhexidine (CHX) throughout the internal fluid path and external catheter body surface to help prevent microbial colonisation and central-line associated bloodstream infections (CLABSI). Chlorhexidine is an ideal broad-spectrum antimicrobial4,5. Recent Australian clinical and economic research highlights the high incidence, substantial avoidable costs and preventability of CLABSI among intensive care unit patients.1-3 Extensive global use of CHX impregnated central venous catheters since the early 1990s has demonstrated their clinical and economic impact in CLABSI prevention.

  1. McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there yet? Crit Care Med. Feb 2012;40(2):388-393.
  2. Burrell AR, McLaws ML, Murgo M, Calabria E, Pantle AC, Herkes R. Aseptic insertion of central venous lines to reduce bacteraemia. Med J Aust. Jun 6 2011;194(11):583-587.
  3. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care. 2009;13(2):R35.
  4. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. May 2011;39(4 Suppl 1):S1-34.
  5. Australian and New Zealand Intensive Care Society. ANZICS Central Line Insertion Maintenance Guidelines April 2012. In: ANZICS Safety and Quality Committee, ed. Melbourne 2012.

Sydney IV Forum - February 2013